Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy

By Kim Ji-Won   Kim Jee   Im Seock-Ah   Lee Kyung-Hun   Kim Jin-Soo   Kim Tae-Yong   Han Sae-Won   Jeon Yoon   Oh Do-Youn   Kim Tae-You   Park In  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1023-1029

Springer Publishing Company

Access to resources Recommend Favorite

Comparative Analysis Between the HER2 Status in Primary Breast Cancer Tissue and the Detection of Isolated Tumor Cells in the Bone Marrow

By Schindlbeck C.   Janni W.   Shabani N.   Rack B.   Gerber B.   Schmitt M.   Harbeck N.   Sommer H.   Braun S.   Friese K.  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 65-74

Springer Publishing Company

Access to resources Recommend Favorite

Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue

By Park In  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 125-128

Springer Publishing Company

Access to resources Recommend Favorite

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

By Lobbezoo Dorien   Kampen Roel   Voogd Adri   Dercksen M.   den Berkmortel Franchette   Smilde Tineke   Wouw Agnes   Peters Frank   Riel Johanna   Peters Natascha   Boer Maaike   Borm George   Tjan-Heijnen Vivianne  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 507-514

Springer Publishing Company

Access to resources Recommend Favorite

Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens

By Manni A.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 2, 2001-05 ,pp. : 147-156

Springer Publishing Company

Access to resources Recommend Favorite